Study of Brain Cools Device in Patients Resuscitated From Cardiac Arrest

NCT03889340 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2021-12-17

No results posted yet for this study

Summary

This submission is a pilot in which the new IQool Warming System device will be used to maintain the temperature of adult patients in cardiac arrest within a range of within a range of 32°C to 38.5°C (89.6°F to 101.3°F). The IQool Warming System has received a 510 K Clearance by the FDA.

Conditions

  • Cardiac Arrest With Successful Resuscitation

Interventions

DEVICE

IQool

Subjects will undergo hypothermia therapy with the IQool system

Sponsors & Collaborators

  • BrainCool

    collaborator UNKNOWN
  • Adam Frisch

    lead OTHER

Principal Investigators

  • Jon Rittenberger, MD · Associate Professor of Emergency Medicine, University of Pittsburgh

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2021-05-31
Completion
2021-12-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03889340 on ClinicalTrials.gov